Novartis

Legal Entities

• NOVARTIS AG

Overview

Novartis AG was created in 1996 through the merger of Ciba-Geigy and Sandoz, headquartered in Basel, Switzerland. It focuses on innovative medicines, generics through Sandoz, and increasingly advanced therapy platforms.

UK trademark portfolios reflect oncology, immunology, and ophthalmology brands alongside corporate identities. Pharmaceutical groups typically concentrate filings in Class 5, while companion diagnostics and digital health extensions can appear in additional classes, showing how brand protection tracks regulated product lifecycles.

Visit Novartis website →